Hercules Capital, Inc. (NYSE:HTGC) Plans $0.07 Quarterly Dividend

Hercules Capital, Inc. (NYSE:HTGC) declared a quarterly dividend on Tuesday, February 10th. Investors of record on Wednesday, February 25th will be given a dividend of 0.07 per share by the financial services provider on Wednesday, March 4th. This represents a c) dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Wednesday, February 25th.

Hercules Capital has increased its dividend by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 1 years. Hercules Capital has a dividend payout ratio of 80.4% meaning its dividend is currently covered by earnings, but may not be in the future if the company’s earnings decline. Research analysts expect Hercules Capital to earn $2.03 per share next year, which means the company should continue to be able to cover its $1.60 annual dividend with an expected future payout ratio of 78.8%.

Hercules Capital Stock Up 0.5%

Shares of HTGC traded up $0.09 during mid-day trading on Tuesday, hitting $16.89. 2,027,693 shares of the company’s stock were exchanged, compared to its average volume of 1,617,596. The firm has a fifty day moving average of $18.51 and a two-hundred day moving average of $18.52. Hercules Capital has a twelve month low of $15.65 and a twelve month high of $22.04. The stock has a market cap of $3.07 billion, a price-to-earnings ratio of 9.82 and a beta of 0.84. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.98.

About Hercules Capital

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company’s investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.